Since 2010, more than 180 countries have seen rising rates of childhood overweight and obesity, according to World Obesity Federation - Anadolu Ajansı ...

Weight loss triggers biological adaptations, including hormonal shifts, metabolic slowing, neural reward changes, and adipose ...

Twenty percent of potentially eligible youth are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), with the ...

Meta-analysis of 64 clinical trials 'should give clinicians and their patients more confidence,' say Hopkins researchers ...

Research presented at AAAAI 2026 suggests GLP-1 RAs may provide clinical benefits for asthma management in patients with excess body weight.

Relying on body weight alone can create a misleading picture of health. Cardiologists explain how tracking certain health ...

Worldwide, breast cancer deaths are projected to increase by 44%, rising to nearly 1.4 million by 2050 from 764,000 in 2023, ...

Characteristics of sarcopenic obesity (SO), including low calf circumference (CC), handgrip strength (HGS) increased  body mass index (BMI) and waist circumference (WC), were associated with an ...

Among six trials that analyzed outcomes for nearly 20,000 participants by sex, women lost an average of 10.88% (95% CI -14.76 to -7) of their baseline body weight on a GLP-1 agent, while men lost 6.8% ...

Building muscle while in a calorie deficit requires high protein intake and strength training. Beginners often see faster muscle growth.

Popular GLP-1 receptor agonist drugs (GLP-1 RAs) for weight loss appear to be similarly effective among patients of different ages, races, and starting weight, with women benefiting somewhat more than ...

Background Cardiovascular disease (CVD) is the leading cause of mortality worldwide, while depression is highly prevalent in this patient population and has long been regarded as an independent risk ...